About Department of Surgery, King Chulalongkorn Memorial Hospital
King Chulalongkorn Memorial Hospital is a public general and tertiary referral hospital in Bangkok, Thailand. It is operated by the Thai Red Cross Society, and serves as the teaching hospital for the Faculty of Medicine, Chulalongkorn University and Srisavarindhira Thai Red Cross Institute of Nursing.
There are 1,435 beds in Department of Surgery, King Chulalongkorn Memorial Hospital.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at Department of Surgery, King Chulalongkorn Memorial Hospital
During the past decade, Department of Surgery, King Chulalongkorn Memorial Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
2015-04-09
2021-06-29
Terminated
631
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Department of Surgery, King Chulalongkorn Memorial Hospital
According to Clinical.Site data, the most researched conditions in "Department of Surgery, King Chulalongkorn Memorial Hospital" are
"Breast Cancer" (2 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Department of Surgery, King Chulalongkorn Memorial Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Department of Surgery, King Chulalongkorn Memorial Hospital
Most popular intervention types in "Department of Surgery, King Chulalongkorn Memorial Hospital" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Fulvestrant" (1 trials), "Herceptin" (1 trials), "Placebo" (1 trials), "Taselisib" (1 trials) and "Trastuzumab Emtansine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Department of Surgery, King Chulalongkorn Memorial Hospital
The vast majority of trials in "Department of Surgery, King Chulalongkorn Memorial Hospital" are
2 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Department of Surgery, King Chulalongkorn Memorial Hospital
Currently, there are NaN active trials in "Department of Surgery, King Chulalongkorn Memorial Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Department of Surgery, King Chulalongkorn Memorial Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Department of Surgery, King Chulalongkorn Memorial Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".